Literature DB >> 24180496

Cancer-drug discovery and cardiovascular surveillance.

John D Groarke1, Susan Cheng, Javid Moslehi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24180496     DOI: 10.1056/NEJMp1313140

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  29 in total

Review 1.  Cardiovascular Complications of Targeted Therapies for Chronic Myeloid Leukemia.

Authors:  Rongras Damrongwatanasuk; Michael G Fradley
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-04

Review 2.  Dysfunction of the ubiquitin-proteasome system in atherosclerotic cardiovascular disease.

Authors:  Feilong Wang; Amir Lerman; Joerg Herrmann
Journal:  Am J Cardiovasc Dis       Date:  2015-03-10

Review 3.  Long-Term Side Effects of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia.

Authors:  Lauren Caldemeyer; Michael Dugan; John Edwards; Luke Akard
Journal:  Curr Hematol Malig Rep       Date:  2016-04       Impact factor: 3.952

4.  Approval after phase I: ceritinib runs the three-minute mile.

Authors:  Bruce A Chabner
Journal:  Oncologist       Date:  2014-05-01

Review 5.  Cardiovascular disease in adult survivors of childhood cancer.

Authors:  Steven E Lipshultz; Vivian I Franco; Tracie L Miller; Steven D Colan; Stephen E Sallan
Journal:  Annu Rev Med       Date:  2015       Impact factor: 13.739

Review 6.  Managing chemotherapy-related cardiotoxicity in survivors of childhood cancers.

Authors:  Steven E Lipshultz; Melissa B Diamond; Vivian I Franco; Sanjeev Aggarwal; Kasey Leger; Maria Verônica Santos; Stephen E Sallan; Eric J Chow
Journal:  Paediatr Drugs       Date:  2014-10       Impact factor: 3.022

7.  A retrospective analysis of 3954 patients in phase 2/3 trials of bortezomib for the treatment of multiple myeloma: towards providing a benchmark for the cardiac safety profile of proteasome inhibition in multiple myeloma.

Authors:  Jacob P Laubach; Javid J Moslehi; Sanjeev A Francis; Jesús F San Miguel; Pieter Sonneveld; Robert Z Orlowski; Philippe Moreau; Laura Rosiñol; Edward A Faber; Peter Voorhees; Maria-Victoria Mateos; Loreta Marquez; Huaibao Feng; Avinash Desai; Helgi van de Velde; Jennifer Elliott; Hongliang Shi; Edward Dow; Nishith Jobanputra; Dixie-Lee Esseltine; Liviu Niculescu; Kenneth C Anderson; Sagar Lonial; Paul G Richardson
Journal:  Br J Haematol       Date:  2017-05-03       Impact factor: 6.998

8.  Recognizing and managing left ventricular dysfunction associated with therapeutic inhibition of the vascular endothelial growth factor signaling pathway.

Authors:  John D Groarke; Toni K Choueiri; David Slosky; Susan Cheng; Javid Moslehi
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-09

Review 9.  Cardio-Oncology: How New Targeted Cancer Therapies and Precision Medicine Can Inform Cardiovascular Discovery.

Authors:  Andrew M Bellinger; Carlos L Arteaga; Thomas Force; Benjamin D Humphreys; George D Demetri; Brian J Druker; Javid J Moslehi
Journal:  Circulation       Date:  2015-12-08       Impact factor: 29.690

10.  How I treat Philadelphia chromosome-positive acute lymphoblastic leukemia.

Authors:  Farhad Ravandi
Journal:  Blood       Date:  2018-11-15       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.